[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Vitamin K2 Market, 2021-2027

November 2021 | 83 pages | ID: G6B992969BBDEN
Gen Consulting Company

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Vitamin K is a fat-soluble vitamin that occurs naturally in two forms: vitamin K1 and vitamin K2. Vitamin K2 is a collection of isoprenologues that mostly originate from bacterial synthesis, also called menaquinones (MKs). It helps the body to clot, or coagulate blood and maintain bone health. The global vitamin K2 market is anticipated to increase by USD 531 million till 2027 at an average annual growth of 23.6 percent as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global vitamin K2 market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The vitamin K2 market is segmented on the basis of product, application, and region. The vitamin K2 market is segmented as below:

By product:
  • MK-7
  • MK-4
  • others
By application:
  • food & beverages
  • nutritional supplements
By region:
  • Asia Pacific
  • Europe
  • North America
  • Rest of the World (RoW)
The report also provides a detailed analysis of several leading vitamin K2 market vendors that include Frutarom Industries Ltd., GeneFerm Biotechnology Co., Ltd., Gnosis by Lesaffre, Guangdong Goodscend Pharm Sci & Tech. Co., Ltd., J-OIL MILLS, INC., Kappa Bioscience AS, Koninklijke DSM N.V., NattoPharma ASA (part of the Gnosis by Lesaffre), Shanghai Reson Biotech Co., Ltd., Strand Biotech Co., Ltd., Vesta Ingredients, Inc., Viridis Biopharma Pvt. Ltd., Xiamen Kingdomway Group Company, Xsto Solutions, LLC, Yuxi Jiankun Bio-Pharmaceutical Co., Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
  • To analyze and forecast the market size of the global vitamin K2 market.
  • To classify and forecast the global vitamin K2 market based on product, application, and region.
  • To identify drivers and challenges for the global vitamin K2 market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global vitamin K2 market.
  • To identify and analyze the profile of leading players operating in the global vitamin K2 market.
Why Choose This Report
  • Gain a reliable outlook of the global vitamin K2 market forecasts from 2021 to 2027 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.
PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR VITAMIN K2 BY PRODUCT

5.1 MK-7
  5.1.1 Market size and forecast
5.2 MK-4
  5.2.1 Market size and forecast
5.3 Others
  5.3.1 Market size and forecast

PART 6. GLOBAL MARKET FOR VITAMIN K2 BY APPLICATION

6.1 Food & beverages
  6.1.1 Market size and forecast
6.2 Nutritional supplements
  6.2.1 Market size and forecast

PART 7. GLOBAL MARKET FOR VITAMIN K2 BY REGION

7.1 Asia Pacific
  7.1.1 Market size and forecast
7.2 Europe
  7.2.1 Market size and forecast
7.3 North America
  7.3.1 Market size and forecast
7.4 Rest of the World (RoW)
  7.4.1 Market size and forecast

PART 8. KEY COMPETITOR PROFILES

8.1 Frutarom Industries Ltd.
8.2 GeneFerm Biotechnology Co., Ltd.
8.3 Gnosis by Lesaffre
8.4 Guangdong Goodscend Pharm Sci & Tech. Co., Ltd.
8.5 J-OIL MILLS, INC.
8.6 Kappa Bioscience AS
8.7 Koninklijke DSM N.V.
8.8 NattoPharma ASA (part of the Gnosis by Lesaffre)
8.9 Shanghai Reson Biotech Co., Ltd.
8.10 Strand Biotech Co., Ltd.
8.11 Vesta Ingredients, Inc.
8.12 Viridis Biopharma Pvt. Ltd.
8.13 Xiamen Kingdomway Group Company
8.14 Xsto Solutions, LLC
8.15 Yuxi Jiankun Bio-Pharmaceutical Co., Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY


More Publications